Envista Holdings Corp (NVST) 10-Year Financial Performance & Capital Metrics

NVST • • Industrial / General

HealthcareMedical EquipmentDental Equipment & ProductsDental Implants & Prosthetics

AboutEnvista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.Show more

Revenue $2.51B -2.2%
EBITDA -$915M -647.6%
Net Income -$1.12B -1016.4%
EPS (Diluted) -6.50 -983.3%
Gross Margin 55.43% -1.9%
EBITDA Margin -36.45% -659.8%
Operating Margin -41.35% -3469.1%
Net Margin -44.56% -1041.2%
ROE -31.47% -1216.1%
ROIC -18.76% -4077.2%
Debt/Equity 0.53 +33.1%
Interest Coverage -22.38 -4603.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading near 52-week high
✓Trading at only 1.4x book value

✗Weaknesses

✗Weak Piotroski F-Score: 3/9

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y1.9%

3Y0.02%

TTM4.73%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM101.14%

EPS CAGR

10Y-

5Y-

3Y-

TTM101.11%

ROCE

10Y Avg1.28%

5Y Avg-1.41%

3Y Avg-4.55%

Latest-20.17%

Peer Comparison

Dental Implants & Prosthetics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NVSTEnvista Holdings Corp	4.06B	24.69	-3.80	-2.18%	0.58%	0.5%	7.46%	0.53

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.81B	2.84B	2.28B	1.93B	2.51B	2.57B	2.57B	2.51B
Revenue Growth %	-	0.01%	-0.2%	-0.16%	0.3%	0.02%	-0%	-0.02%
Cost of Goods Sold+	1.18B	1.23B	933.1M	856M	1.05B	1.08B	1.12B	1.12B
COGS % of Revenue	0.42%	0.43%	0.41%	0.44%	0.42%	0.42%	0.43%	0.45%
Gross Profit+	1.63B	1.61B	1.35B	1.07B	1.46B	1.49B	1.45B	1.39B
Gross Margin %	0.58%	0.57%	0.59%	0.56%	0.58%	0.58%	0.57%	0.55%
Gross Profit Growth %	-	-0.01%	-0.16%	-0.21%	0.36%	0.02%	-0.03%	-0.04%
Operating Expenses+	1.24B	1.31B	1.12B	1.03B	1.16B	1.17B	1.42B	2.43B
OpEx % of Revenue	0.44%	0.46%	0.49%	0.53%	0.46%	0.46%	0.55%	0.97%
Selling, General & Admin	1.03B	1.11B	970.1M	858.8M	989.5M	1.03B	1.03B	1.14B
SG&A % of Revenue	0.37%	0.39%	0.42%	0.45%	0.39%	0.4%	0.4%	0.45%
Research & Development	172.4M	172M	133.1M	86.7M	100.5M	100.1M	93.8M	99.1M
R&D % of Revenue	0.06%	0.06%	0.06%	0.04%	0.04%	0.04%	0.04%	0.04%
Other Operating Expenses	35.9M	26.4M	12.8M	84.1M	66.2M	40.7M	295.9M	1.19B
Operating Income+	386.6M	298.4M	235.7M	43.5M	306.2M	319.2M	31.5M	-1.04B
Operating Margin %	0.14%	0.1%	0.1%	0.02%	0.12%	0.12%	0.01%	-0.41%
Operating Income Growth %	-	-0.23%	-0.21%	-0.82%	6.04%	0.04%	-0.9%	-33.96%
EBITDA+	508M	428.4M	364.2M	176.1M	429.8M	457M	167.1M	-915.1M
EBITDA Margin %	0.18%	0.15%	0.16%	0.09%	0.17%	0.18%	0.07%	-0.36%
EBITDA Growth %	-	-0.16%	-0.15%	-0.52%	1.44%	0.06%	-0.63%	-6.48%
D&A (Non-Cash Add-back)	121.4M	130M	128.5M	132.6M	123.6M	137.8M	135.6M	123.1M
EBIT	422.5M	324.8M	248.5M	127.6M	372.4M	359.9M	327.4M	156.4M
Net Interest Income+	0	0	-3.5M	-62.5M	-54.1M	-38.4M	-63.4M	-46.4M
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	0	0	3.5M	62.5M	54.1M	38.4M	63.4M	46.4M
Other Income/Expense	100K	2.7M	-2M	-63.5M	-51.7M	-35.3M	-86.4M	-46.5M
Pretax Income+	386.7M	301.1M	233.7M	-20M	254.5M	283.9M	-54.9M	-1.08B
Pretax Margin %	0.14%	0.11%	0.1%	-0.01%	0.1%	0.11%	-0.02%	-0.43%
Income Tax+	85.6M	70.4M	49.6M	-62.5M	-9M	45.9M	45.3M	33.9M
Effective Tax Rate %	0.78%	0.77%	0.93%	-1.67%	1.34%	0.86%	1.83%	1.03%
Net Income+	301.1M	230.7M	217.6M	33.3M	340.5M	243.1M	-100.2M	-1.12B
Net Margin %	0.11%	0.08%	0.1%	0.02%	0.14%	0.09%	-0.04%	-0.45%
Net Income Growth %	-	-0.23%	-0.06%	-0.85%	9.23%	-0.29%	-1.41%	-10.16%
Net Income (Continuing)	301.1M	230.7M	184.1M	42.5M	263.5M	238M	-100.2M	-1.12B
Discontinued Operations	0	0	33.5M	-9.2M	77M	5.1M	0	0
Minority Interest	4.1M	3.3M	2.6M	400K	400K	0	0	0
EPS (Diluted)+	2.35	1.80	1.35	0.26	1.48	1.34	-0.60	-6.50
EPS Growth %	-	-0.23%	-0.25%	-0.81%	4.69%	-0.09%	-1.45%	-9.83%
EPS (Basic)	2.35	1.80	1.35	0.27	1.63	1.46	-0.60	-6.50
Diluted Shares Outstanding	154.6M	154.6M	136.4M	164.1M	177.6M	177.6M	166.9M	172.2M
Basic Shares Outstanding	154.6M	154.6M	136.2M	159.6M	161.2M	162.9M	166.9M	172.2M
Dividend Payout Ratio	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	794.5M	786.8M	1B	1.59B	1.84B	1.42B	1.74B	1.79B
Cash & Short-Term Investments	0	0	211.2M	888.9M	1.07B	606.9M	940M	1.07B
Cash Only	0	0	211.2M	888.9M	1.07B	606.9M	940M	1.07B
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	463.1M	459.8M	443.6M	301.7M	331.9M	393.5M	407.5M	363M
Days Sales Outstanding	60.13	59	70.87	57.08	48.29	55.91	57.95	52.77
Inventory	275.7M	278.7M	277.9M	216M	263.8M	300.8M	258.8M	241M
Days Inventory Outstanding	85.04	82.38	108.71	92.1	92.01	101.59	84.64	78.61
Other Current Assets	0	0	0	113.9M	12.2M	123.4M	137.4M	115.2M
Total Non-Current Assets+	5.2B	5.05B	5.16B	5.29B	4.74B	5.16B	4.86B	3.56B
Property, Plant & Equipment	231.2M	261.6M	490.4M	437.3M	392.2M	425.4M	434.7M	419.8M
Fixed Asset Turnover	12.16x	10.87x	4.66x	4.41x	6.40x	6.04x	5.90x	5.98x
Goodwill	3.37B	3.33B	3.31B	3.21B	3.13B	3.5B	3.29B	2.26B
Intangible Assets	1.52B	1.39B	1.29B	1.15B	1.05B	1.09B	954M	649.9M
Long-Term Investments	-143.2M	-130.8M	0	0	-160.5M	0	0	26.4M
Other Non-Current Assets	81.2M	77.4M	74.4M	488M	167.8M	153.7M	180.5M	204.2M
Total Assets+	5.99B	5.84B	6.16B	6.88B	6.57B	6.59B	6.61B	5.35B
Asset Turnover	0.47x	0.49x	0.37x	0.28x	0.38x	0.39x	0.39x	0.47x
Asset Growth %	-	-0.03%	0.05%	0.12%	-0.04%	0%	0%	-0.19%
Total Current Liabilities+	628.2M	641M	709.2M	1.68B	1.21B	1.24B	780.8M	878.7M
Accounts Payable	222.4M	217.4M	208M	202.5M	185.8M	228.3M	179.5M	174.6M
Days Payables Outstanding	68.6	64.26	81.36	86.35	64.8	77.11	58.71	56.95
Short-Term Debt	0	0	3.9M	886.8M	456.1M	510M	115.3M	116M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	281.2M	302.5M	309.9M	414.5M	407.1M	265.3M	277.3M	407.1M
Current Ratio	1.26x	1.23x	1.41x	0.94x	1.52x	1.15x	2.23x	2.04x
Quick Ratio	0.83x	0.79x	1.02x	0.82x	1.30x	0.91x	1.90x	1.76x
Cash Conversion Cycle	76.57	77.12	98.21	62.84	75.49	80.39	83.89	74.43
Total Non-Current Liabilities+	370M	374.2M	1.91B	1.47B	1.31B	1.14B	1.65B	1.54B
Long-Term Debt	0	0	1.32B	907.7M	883.4M	870.7M	1.4B	1.28B
Capital Lease Obligations	0	0	186M	152.6M	120.4M	121.4M	109.9M	118.9M
Deferred Tax Liabilities	0	0	0	0	-5.1M	0	0	0
Other Non-Current Liabilities	365.9M	370.2M	394.9M	406.4M	299.1M	142.7M	134M	119.5M
Total Liabilities	998.2M	1.02B	2.62B	3.15B	2.52B	2.38B	2.43B	2.42B
Total Debt+	0	0	1.54B	1.98B	1.48B	1.53B	1.65B	1.55B
Net Debt	0	0	1.33B	1.09B	410M	922.2M	713.6M	478.6M
Debt / Equity	-	-	0.43x	0.53x	0.37x	0.36x	0.40x	0.53x
Debt / EBITDA	-	-	4.22x	11.23x	3.45x	3.35x	9.90x	-
Net Debt / EBITDA	-	-	3.64x	6.19x	0.95x	2.02x	4.27x	-
Interest Coverage	-	-	67.34x	0.70x	5.66x	8.31x	0.50x	-22.38x
Total Equity+	4.99B	4.83B	3.54B	3.72B	4.06B	4.21B	4.17B	2.93B
Equity Growth %	-	-0.03%	-0.27%	0.05%	0.09%	0.04%	-0.01%	-0.3%
Book Value per Share	32.31	31.22	25.97	22.68	22.85	23.69	25.01	17.04
Total Shareholders' Equity	4.99B	4.82B	3.54B	3.72B	4.06B	4.21B	4.17B	2.93B
Common Stock	4.99B	4.9B	1.6M	1.6M	1.6M	1.6M	1.7M	1.7M
Retained Earnings	0	0	93.1M	126.4M	466.9M	731.4M	631.2M	-487.4M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	600K	-78.2M	-144.2M	-91.8M	-143.5M	-225.1M	-217.2M	-371.1M
Minority Interest	4.1M	3.3M	2.6M	400K	400K	0	0	0

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	359.1M	400.1M	397.5M	283.9M	361.6M	182.7M	275.7M	336.5M
Operating CF Margin %	0.13%	0.14%	0.17%	0.15%	0.14%	0.07%	0.11%	0.13%
Operating CF Growth %	-	0.11%	-0.01%	-0.29%	0.27%	-0.49%	0.51%	0.22%
Net Income	301.1M	230.7M	217.6M	33.3M	340.5M	243.1M	-100.2M	-1.12B
Depreciation & Amortization	121.4M	130M	168.1M	163.1M	151.9M	162.1M	162.6M	154.5M
Stock-Based Compensation	12.3M	13.3M	18.4M	22.6M	28.2M	30.5M	30.7M	35.3M
Deferred Taxes	-58.2M	1.7M	0	55.6M	0	0	-37M	-29M
Other Non-Cash Items	6.8M	400K	9.5M	24.5M	44.2M	18.7M	328M	1.2B
Working Capital Changes	-82.5M	25.7M	-16.1M	-15.2M	-203.2M	-271.7M	-108.4M	97.4M
Change in Receivables	-18.9M	-3.8M	3.3M	71.9M	-43.2M	-71M	-17M	10M
Change in Inventory	-30.5M	-8.9M	-1.5M	11.9M	-66M	-39.9M	35.1M	3.6M
Change in Payables	-500K	-3.8M	-7.9M	21.6M	-20.3M	44.5M	-46.3M	-1.2M
Cash from Investing+	-54.9M	-75.5M	-78.4M	-69.1M	262.7M	-657.3M	-62.4M	-54.6M
Capital Expenditures	-48.9M	-72.2M	-77.8M	-47.7M	-54.7M	-75.7M	-58.2M	-33.8M
CapEx % of Revenue	0.02%	0.03%	0.03%	0.02%	0.02%	0.03%	0.02%	0.01%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-6M	-3.3M	-600K	19.3M	-4.4M	-15.3M	-14.9M	2.3M
Cash from Financing+	-304.2M	-324.6M	-107.7M	492.5M	-465.6M	12.5M	118.9M	-103.7M
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-304.2M	-324.6M	-2.07B	-19.8M	10.1M	12.7M	-6.9M	-6.1M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	310.2M	327.9M	319.7M	236.2M	306.9M	107M	217.5M	302.7M
FCF Margin %	0.11%	0.12%	0.14%	0.12%	0.12%	0.04%	0.08%	0.12%
FCF Growth %	-	0.06%	-0.03%	-0.26%	0.3%	-0.65%	1.03%	0.39%
FCF per Share	2.01	2.12	2.34	1.44	1.73	0.60	1.30	1.76
FCF Conversion (FCF/Net Income)	1.19x	1.73x	1.83x	8.53x	1.06x	0.75x	-2.75x	-0.30x
Interest Paid	0	0	7.7M	56.7M	35.7M	38.4M	63.2M	54.7M
Taxes Paid	25.1M	26.3M	30.7M	28.6M	84M	119.2M	98.6M	32.9M

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	6.03%	4.7%	5.2%	0.92%	8.75%	5.88%	-2.39%	-31.47%
Return on Invested Capital (ROIC)	5.81%	4.56%	3.65%	0.67%	4.95%	4.99%	0.47%	-18.76%
Gross Margin	57.9%	56.59%	59.16%	55.63%	58.29%	57.93%	56.52%	55.43%
Net Margin	10.71%	8.11%	9.52%	1.73%	13.57%	9.46%	-3.9%	-44.56%
Debt / Equity	-	-	0.43x	0.53x	0.37x	0.36x	0.40x	0.53x
Interest Coverage	-	-	67.34x	0.70x	5.66x	8.31x	0.50x	-22.38x
FCF Conversion	1.19x	1.73x	1.83x	8.53x	1.06x	0.75x	-2.75x	-0.30x
Revenue Growth	-	1.2%	-19.68%	-15.57%	30.06%	2.4%	-0.1%	-2.18%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Specialty Products and Technologies	-	-	-	-	1.64B	1.62B
Specialty Products and Technologies Growth	-	-	-	-	-	-1.58%
Equipment and Consumables	-	-	-	-	924.1M	894.2M
Equipment and Consumables Growth	-	-	-	-	-	-3.24%
Consumables	1.87B	1.59B	2.07B	2.15B	-	-
Consumables Growth	-	-14.75%	29.72%	3.85%	-	-
Equipment Sales	881.7M	687.9M	441M	421.6M	-	-
Equipment Sales Growth	-	-21.98%	-35.89%	-4.40%	-	-

Revenue by Geography

	2019	2020	2021	2022	2023	2024
UNITED STATES	1.21B	1.01B	1.22B	1.26B	1.21B	1.2B
UNITED STATES Growth	-	-16.33%	20.78%	3.15%	-4.16%	-0.54%
All Other Countries	1.18B	908.9M	1.05B	1.08B	1.15B	1.11B
All Other Countries Growth	-	-22.77%	15.39%	3.45%	6.12%	-3.23%
CHINA	212.8M	215.6M	236.7M	222.2M	205.7M	193.5M
CHINA Growth	-	1.32%	9.79%	-6.13%	-7.43%	-5.93%
GERMANY	151.3M	144.6M	-	-	-	-
GERMANY Growth	-	-4.43%	-	-	-	-

Frequently Asked Questions

Growth & Financials

Envista Holdings Corp (NVST) reported $2.62B in revenue for fiscal year 2024. This represents a 7% decrease from $2.81B in 2017.

Envista Holdings Corp (NVST) saw revenue decline by 2.2% over the past year.

Yes, Envista Holdings Corp (NVST) is profitable, generating $15.3M in net income for fiscal year 2024 (-44.6% net margin).

Dividend & Returns

Envista Holdings Corp (NVST) has a return on equity (ROE) of -31.5%. Negative ROE indicates the company is unprofitable.

Envista Holdings Corp (NVST) generated $262.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Envista Holdings Corp (NVST) 10-Year Financial Performance & Capital Metrics

NVST • • Industrial / General

HealthcareMedical EquipmentDental Equipment & ProductsDental Implants & Prosthetics

Revenue $2.51B -2.2%
EBITDA -$915M -647.6%
Net Income -$1.12B -1016.4%
EPS (Diluted) -6.50 -983.3%
Gross Margin 55.43% -1.9%
EBITDA Margin -36.45% -659.8%
Operating Margin -41.35% -3469.1%
Net Margin -44.56% -1041.2%
ROE -31.47% -1216.1%
ROIC -18.76% -4077.2%
Debt/Equity 0.53 +33.1%
Interest Coverage -22.38 -4603.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading near 52-week high
✓Trading at only 1.4x book value

✗Weaknesses

✗Weak Piotroski F-Score: 3/9

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y1.9%

3Y0.02%

TTM4.73%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM101.14%

EPS CAGR

10Y-

5Y-

3Y-

TTM101.11%

ROCE

10Y Avg1.28%

5Y Avg-1.41%

3Y Avg-4.55%

Latest-20.17%

Peer Comparison

Dental Implants & Prosthetics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NVSTEnvista Holdings Corp	4.06B	24.69	-3.80	-2.18%	0.58%	0.5%	7.46%	0.53

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.81B	2.84B	2.28B	1.93B	2.51B	2.57B	2.57B	2.51B
Revenue Growth %	-	0.01%	-0.2%	-0.16%	0.3%	0.02%	-0%	-0.02%
Cost of Goods Sold+	1.18B	1.23B	933.1M	856M	1.05B	1.08B	1.12B	1.12B
COGS % of Revenue	0.42%	0.43%	0.41%	0.44%	0.42%	0.42%	0.43%	0.45%
Gross Profit+	1.63B	1.61B	1.35B	1.07B	1.46B	1.49B	1.45B	1.39B
Gross Margin %	0.58%	0.57%	0.59%	0.56%	0.58%	0.58%	0.57%	0.55%
Gross Profit Growth %	-	-0.01%	-0.16%	-0.21%	0.36%	0.02%	-0.03%	-0.04%
Operating Expenses+	1.24B	1.31B	1.12B	1.03B	1.16B	1.17B	1.42B	2.43B
OpEx % of Revenue	0.44%	0.46%	0.49%	0.53%	0.46%	0.46%	0.55%	0.97%
Selling, General & Admin	1.03B	1.11B	970.1M	858.8M	989.5M	1.03B	1.03B	1.14B
SG&A % of Revenue	0.37%	0.39%	0.42%	0.45%	0.39%	0.4%	0.4%	0.45%
Research & Development	172.4M	172M	133.1M	86.7M	100.5M	100.1M	93.8M	99.1M
R&D % of Revenue	0.06%	0.06%	0.06%	0.04%	0.04%	0.04%	0.04%	0.04%
Other Operating Expenses	35.9M	26.4M	12.8M	84.1M	66.2M	40.7M	295.9M	1.19B
Operating Income+	386.6M	298.4M	235.7M	43.5M	306.2M	319.2M	31.5M	-1.04B
Operating Margin %	0.14%	0.1%	0.1%	0.02%	0.12%	0.12%	0.01%	-0.41%
Operating Income Growth %	-	-0.23%	-0.21%	-0.82%	6.04%	0.04%	-0.9%	-33.96%
EBITDA+	508M	428.4M	364.2M	176.1M	429.8M	457M	167.1M	-915.1M
EBITDA Margin %	0.18%	0.15%	0.16%	0.09%	0.17%	0.18%	0.07%	-0.36%
EBITDA Growth %	-	-0.16%	-0.15%	-0.52%	1.44%	0.06%	-0.63%	-6.48%
D&A (Non-Cash Add-back)	121.4M	130M	128.5M	132.6M	123.6M	137.8M	135.6M	123.1M
EBIT	422.5M	324.8M	248.5M	127.6M	372.4M	359.9M	327.4M	156.4M
Net Interest Income+	0	0	-3.5M	-62.5M	-54.1M	-38.4M	-63.4M	-46.4M
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	0	0	3.5M	62.5M	54.1M	38.4M	63.4M	46.4M
Other Income/Expense	100K	2.7M	-2M	-63.5M	-51.7M	-35.3M	-86.4M	-46.5M
Pretax Income+	386.7M	301.1M	233.7M	-20M	254.5M	283.9M	-54.9M	-1.08B
Pretax Margin %	0.14%	0.11%	0.1%	-0.01%	0.1%	0.11%	-0.02%	-0.43%
Income Tax+	85.6M	70.4M	49.6M	-62.5M	-9M	45.9M	45.3M	33.9M
Effective Tax Rate %	0.78%	0.77%	0.93%	-1.67%	1.34%	0.86%	1.83%	1.03%
Net Income+	301.1M	230.7M	217.6M	33.3M	340.5M	243.1M	-100.2M	-1.12B
Net Margin %	0.11%	0.08%	0.1%	0.02%	0.14%	0.09%	-0.04%	-0.45%
Net Income Growth %	-	-0.23%	-0.06%	-0.85%	9.23%	-0.29%	-1.41%	-10.16%
Net Income (Continuing)	301.1M	230.7M	184.1M	42.5M	263.5M	238M	-100.2M	-1.12B
Discontinued Operations	0	0	33.5M	-9.2M	77M	5.1M	0	0
Minority Interest	4.1M	3.3M	2.6M	400K	400K	0	0	0
EPS (Diluted)+	2.35	1.80	1.35	0.26	1.48	1.34	-0.60	-6.50
EPS Growth %	-	-0.23%	-0.25%	-0.81%	4.69%	-0.09%	-1.45%	-9.83%
EPS (Basic)	2.35	1.80	1.35	0.27	1.63	1.46	-0.60	-6.50
Diluted Shares Outstanding	154.6M	154.6M	136.4M	164.1M	177.6M	177.6M	166.9M	172.2M
Basic Shares Outstanding	154.6M	154.6M	136.2M	159.6M	161.2M	162.9M	166.9M	172.2M
Dividend Payout Ratio	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	794.5M	786.8M	1B	1.59B	1.84B	1.42B	1.74B	1.79B
Cash & Short-Term Investments	0	0	211.2M	888.9M	1.07B	606.9M	940M	1.07B
Cash Only	0	0	211.2M	888.9M	1.07B	606.9M	940M	1.07B
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	463.1M	459.8M	443.6M	301.7M	331.9M	393.5M	407.5M	363M
Days Sales Outstanding	60.13	59	70.87	57.08	48.29	55.91	57.95	52.77
Inventory	275.7M	278.7M	277.9M	216M	263.8M	300.8M	258.8M	241M
Days Inventory Outstanding	85.04	82.38	108.71	92.1	92.01	101.59	84.64	78.61
Other Current Assets	0	0	0	113.9M	12.2M	123.4M	137.4M	115.2M
Total Non-Current Assets+	5.2B	5.05B	5.16B	5.29B	4.74B	5.16B	4.86B	3.56B
Property, Plant & Equipment	231.2M	261.6M	490.4M	437.3M	392.2M	425.4M	434.7M	419.8M
Fixed Asset Turnover	12.16x	10.87x	4.66x	4.41x	6.40x	6.04x	5.90x	5.98x
Goodwill	3.37B	3.33B	3.31B	3.21B	3.13B	3.5B	3.29B	2.26B
Intangible Assets	1.52B	1.39B	1.29B	1.15B	1.05B	1.09B	954M	649.9M
Long-Term Investments	-143.2M	-130.8M	0	0	-160.5M	0	0	26.4M
Other Non-Current Assets	81.2M	77.4M	74.4M	488M	167.8M	153.7M	180.5M	204.2M
Total Assets+	5.99B	5.84B	6.16B	6.88B	6.57B	6.59B	6.61B	5.35B
Asset Turnover	0.47x	0.49x	0.37x	0.28x	0.38x	0.39x	0.39x	0.47x
Asset Growth %	-	-0.03%	0.05%	0.12%	-0.04%	0%	0%	-0.19%
Total Current Liabilities+	628.2M	641M	709.2M	1.68B	1.21B	1.24B	780.8M	878.7M
Accounts Payable	222.4M	217.4M	208M	202.5M	185.8M	228.3M	179.5M	174.6M
Days Payables Outstanding	68.6	64.26	81.36	86.35	64.8	77.11	58.71	56.95
Short-Term Debt	0	0	3.9M	886.8M	456.1M	510M	115.3M	116M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	281.2M	302.5M	309.9M	414.5M	407.1M	265.3M	277.3M	407.1M
Current Ratio	1.26x	1.23x	1.41x	0.94x	1.52x	1.15x	2.23x	2.04x
Quick Ratio	0.83x	0.79x	1.02x	0.82x	1.30x	0.91x	1.90x	1.76x
Cash Conversion Cycle	76.57	77.12	98.21	62.84	75.49	80.39	83.89	74.43
Total Non-Current Liabilities+	370M	374.2M	1.91B	1.47B	1.31B	1.14B	1.65B	1.54B
Long-Term Debt	0	0	1.32B	907.7M	883.4M	870.7M	1.4B	1.28B
Capital Lease Obligations	0	0	186M	152.6M	120.4M	121.4M	109.9M	118.9M
Deferred Tax Liabilities	0	0	0	0	-5.1M	0	0	0
Other Non-Current Liabilities	365.9M	370.2M	394.9M	406.4M	299.1M	142.7M	134M	119.5M
Total Liabilities	998.2M	1.02B	2.62B	3.15B	2.52B	2.38B	2.43B	2.42B
Total Debt+	0	0	1.54B	1.98B	1.48B	1.53B	1.65B	1.55B
Net Debt	0	0	1.33B	1.09B	410M	922.2M	713.6M	478.6M
Debt / Equity	-	-	0.43x	0.53x	0.37x	0.36x	0.40x	0.53x
Debt / EBITDA	-	-	4.22x	11.23x	3.45x	3.35x	9.90x	-
Net Debt / EBITDA	-	-	3.64x	6.19x	0.95x	2.02x	4.27x	-
Interest Coverage	-	-	67.34x	0.70x	5.66x	8.31x	0.50x	-22.38x
Total Equity+	4.99B	4.83B	3.54B	3.72B	4.06B	4.21B	4.17B	2.93B
Equity Growth %	-	-0.03%	-0.27%	0.05%	0.09%	0.04%	-0.01%	-0.3%
Book Value per Share	32.31	31.22	25.97	22.68	22.85	23.69	25.01	17.04
Total Shareholders' Equity	4.99B	4.82B	3.54B	3.72B	4.06B	4.21B	4.17B	2.93B
Common Stock	4.99B	4.9B	1.6M	1.6M	1.6M	1.6M	1.7M	1.7M
Retained Earnings	0	0	93.1M	126.4M	466.9M	731.4M	631.2M	-487.4M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	600K	-78.2M	-144.2M	-91.8M	-143.5M	-225.1M	-217.2M	-371.1M
Minority Interest	4.1M	3.3M	2.6M	400K	400K	0	0	0

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	359.1M	400.1M	397.5M	283.9M	361.6M	182.7M	275.7M	336.5M
Operating CF Margin %	0.13%	0.14%	0.17%	0.15%	0.14%	0.07%	0.11%	0.13%
Operating CF Growth %	-	0.11%	-0.01%	-0.29%	0.27%	-0.49%	0.51%	0.22%
Net Income	301.1M	230.7M	217.6M	33.3M	340.5M	243.1M	-100.2M	-1.12B
Depreciation & Amortization	121.4M	130M	168.1M	163.1M	151.9M	162.1M	162.6M	154.5M
Stock-Based Compensation	12.3M	13.3M	18.4M	22.6M	28.2M	30.5M	30.7M	35.3M
Deferred Taxes	-58.2M	1.7M	0	55.6M	0	0	-37M	-29M
Other Non-Cash Items	6.8M	400K	9.5M	24.5M	44.2M	18.7M	328M	1.2B
Working Capital Changes	-82.5M	25.7M	-16.1M	-15.2M	-203.2M	-271.7M	-108.4M	97.4M
Change in Receivables	-18.9M	-3.8M	3.3M	71.9M	-43.2M	-71M	-17M	10M
Change in Inventory	-30.5M	-8.9M	-1.5M	11.9M	-66M	-39.9M	35.1M	3.6M
Change in Payables	-500K	-3.8M	-7.9M	21.6M	-20.3M	44.5M	-46.3M	-1.2M
Cash from Investing+	-54.9M	-75.5M	-78.4M	-69.1M	262.7M	-657.3M	-62.4M	-54.6M
Capital Expenditures	-48.9M	-72.2M	-77.8M	-47.7M	-54.7M	-75.7M	-58.2M	-33.8M
CapEx % of Revenue	0.02%	0.03%	0.03%	0.02%	0.02%	0.03%	0.02%	0.01%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-6M	-3.3M	-600K	19.3M	-4.4M	-15.3M	-14.9M	2.3M
Cash from Financing+	-304.2M	-324.6M	-107.7M	492.5M	-465.6M	12.5M	118.9M	-103.7M
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-304.2M	-324.6M	-2.07B	-19.8M	10.1M	12.7M	-6.9M	-6.1M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	310.2M	327.9M	319.7M	236.2M	306.9M	107M	217.5M	302.7M
FCF Margin %	0.11%	0.12%	0.14%	0.12%	0.12%	0.04%	0.08%	0.12%
FCF Growth %	-	0.06%	-0.03%	-0.26%	0.3%	-0.65%	1.03%	0.39%
FCF per Share	2.01	2.12	2.34	1.44	1.73	0.60	1.30	1.76
FCF Conversion (FCF/Net Income)	1.19x	1.73x	1.83x	8.53x	1.06x	0.75x	-2.75x	-0.30x
Interest Paid	0	0	7.7M	56.7M	35.7M	38.4M	63.2M	54.7M
Taxes Paid	25.1M	26.3M	30.7M	28.6M	84M	119.2M	98.6M	32.9M

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	6.03%	4.7%	5.2%	0.92%	8.75%	5.88%	-2.39%	-31.47%
Return on Invested Capital (ROIC)	5.81%	4.56%	3.65%	0.67%	4.95%	4.99%	0.47%	-18.76%
Gross Margin	57.9%	56.59%	59.16%	55.63%	58.29%	57.93%	56.52%	55.43%
Net Margin	10.71%	8.11%	9.52%	1.73%	13.57%	9.46%	-3.9%	-44.56%
Debt / Equity	-	-	0.43x	0.53x	0.37x	0.36x	0.40x	0.53x
Interest Coverage	-	-	67.34x	0.70x	5.66x	8.31x	0.50x	-22.38x
FCF Conversion	1.19x	1.73x	1.83x	8.53x	1.06x	0.75x	-2.75x	-0.30x
Revenue Growth	-	1.2%	-19.68%	-15.57%	30.06%	2.4%	-0.1%	-2.18%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Specialty Products and Technologies	-	-	-	-	1.64B	1.62B
Specialty Products and Technologies Growth	-	-	-	-	-	-1.58%
Equipment and Consumables	-	-	-	-	924.1M	894.2M
Equipment and Consumables Growth	-	-	-	-	-	-3.24%
Consumables	1.87B	1.59B	2.07B	2.15B	-	-
Consumables Growth	-	-14.75%	29.72%	3.85%	-	-
Equipment Sales	881.7M	687.9M	441M	421.6M	-	-
Equipment Sales Growth	-	-21.98%	-35.89%	-4.40%	-	-

Revenue by Geography

	2019	2020	2021	2022	2023	2024
UNITED STATES	1.21B	1.01B	1.22B	1.26B	1.21B	1.2B
UNITED STATES Growth	-	-16.33%	20.78%	3.15%	-4.16%	-0.54%
All Other Countries	1.18B	908.9M	1.05B	1.08B	1.15B	1.11B
All Other Countries Growth	-	-22.77%	15.39%	3.45%	6.12%	-3.23%
CHINA	212.8M	215.6M	236.7M	222.2M	205.7M	193.5M
CHINA Growth	-	1.32%	9.79%	-6.13%	-7.43%	-5.93%
GERMANY	151.3M	144.6M	-	-	-	-
GERMANY Growth	-	-4.43%	-	-	-	-

Frequently Asked Questions

Growth & Financials

Envista Holdings Corp (NVST) reported $2.62B in revenue for fiscal year 2024. This represents a 7% decrease from $2.81B in 2017.

Envista Holdings Corp (NVST) saw revenue decline by 2.2% over the past year.

Yes, Envista Holdings Corp (NVST) is profitable, generating $15.3M in net income for fiscal year 2024 (-44.6% net margin).

Dividend & Returns

Envista Holdings Corp (NVST) has a return on equity (ROE) of -31.5%. Negative ROE indicates the company is unprofitable.

Envista Holdings Corp (NVST) generated $262.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.